Sterling Capital Management LLC Enochian Biosciences Inc Call Options Transaction History
Sterling Capital Management LLC
- $7.3 Trillion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ENOB
# of Institutions
58Shares Held
18.8MCall Options Held
45.8KPut Options Held
3K-
Vanguard Group Inc Valley Forge, PA5.72MShares$26.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$16.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$10.7 Million0.0% of portfolio
-
State Street Corp Boston, MA2.06MShares$9.5 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL889KShares$4.09 Million0.0% of portfolio
About Enochian Biosciences Inc
- Ticker ENOB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,950,000
- Market Cap $244M
- Description
- Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...